Aspirin And Heart Health: What You Need To Know
Understanding aspirin's role in heart health: benefits, risks, and who should take it.

Is Taking Aspirin Good for Your Heart?
Aspirin has been a staple in cardiovascular health for decades, with many people taking it daily to prevent heart attacks and strokes. However, recent medical research and updated guidelines have sparked important conversations about when aspirin is truly beneficial and when it might do more harm than good. Understanding the nuances of aspirin use is essential for making informed decisions about your heart health.
Understanding Aspirin and How It Works
Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting platelet development and thinning the blood. This blood-thinning mechanism helps reduce the formation of blood clots that could block arteries and lead to a heart attack or stroke. By preventing these clots from forming or growing larger, aspirin can help maintain better blood flow through your cardiovascular system.
The medication has been used for cardiovascular prevention for over a century, with extensive research supporting its effectiveness. However, this same blood-thinning property that helps prevent clots also increases the risk of bleeding complications, creating what medical professionals call a “double-edged sword” effect.
Primary Prevention vs. Secondary Prevention
When discussing aspirin for heart health, it’s crucial to understand two distinct categories: primary prevention and secondary prevention. These terms refer to different populations and have different risk-benefit profiles.
What is Primary Prevention?
Primary prevention involves using aspirin to reduce the risk of a first heart attack or stroke in people who have never experienced these cardiovascular events. For decades, healthy adults considered at risk for heart disease took aspirin regularly to prevent an initial cardiovascular event.
Recent clinical trials have challenged the assumption that aspirin is beneficial for primary prevention in most people. Multiple studies published in recent years have shown that the benefit from taking daily low-dose aspirin is often offset by the increased danger of internal bleeding and other side effects in people at low or moderate risk for heart disease.
What is Secondary Prevention?
Secondary prevention refers to using aspirin to reduce the risk of a second or additional heart attack or stroke in people who have already experienced a cardiovascular event. This population includes individuals who have survived a previous heart attack, stroke, or undergone coronary procedures like bypass surgery or stent insertion.
Unlike primary prevention, available research on secondary prevention shows that the benefits of taking aspirin far outweigh the risks for people who have already had a heart attack or stroke. People who have already experienced a cardiovascular event are at significantly higher risk for recurrent vascular events, meaning they derive greater net benefit from aspirin therapy.
Current Medical Guidelines and Recommendations
Primary Prevention Guidelines
The landscape of aspirin recommendations has shifted dramatically based on recent evidence. The U.S. Preventive Services Task Force now recommends against adults 60 and older starting on low-dose aspirin for primary prevention of cardiovascular disease. For people ages 40 to 59, the Task Force recommends that aspirin might be considered only for those with a 10-year atherosclerotic cardiovascular disease (ASCVD) risk of 10% or higher and who are not at increased risk of bleeding.
The American Heart Association and American College of Cardiology have also updated their prevention guidelines to advise against daily aspirin use for primary prevention in most healthy adults. These organizations emphasize the “first, do no harm” principle, recognizing that for the majority of otherwise healthy adults, the benefit of taking aspirin for primary prevention does not outweigh the risks.
Secondary Prevention Guidelines
Guidelines for secondary prevention remain much more supportive of aspirin use. People who have already had a heart attack, stroke, or undergone coronary procedures should continue to take low-dose aspirin daily as recommended by their healthcare provider to prevent another occurrence. The evidence supporting this use is robust and well-established.
Who Should Take Aspirin?
Clear Candidates for Aspirin Therapy
Certain populations have clear indications for aspirin use:
- People who have survived a heart attack or stroke
- Individuals who have undergone bypass surgery or stent insertion
- Those with diagnosed coronary artery disease
- Patients with established cardiovascular disease requiring secondary prevention
For these individuals, the cardiovascular benefits of aspirin significantly outweigh the bleeding risks.
Selective Candidates for Primary Prevention
For primary prevention in healthy individuals without prior cardiovascular events, aspirin might be considered only in very select circumstances:
- Adults ages 40-70 with a strong family history of heart disease
- Those with test results showing considerable plaque buildup in arteries (detected via coronary calcium scans)
- Individuals at very high calculated risk for cardiovascular disease who are not at increased bleeding risk
Any decision about aspirin for primary prevention should be made in consultation with a healthcare provider who can evaluate individual risk factors.
Who Should Avoid Aspirin
Certain populations should not take aspirin without explicit medical approval:
- Adults over 70 years old (especially for primary prevention)
- People at increased risk for internal bleeding
- Those with a history of gastrointestinal ulcers or bleeding disorders
- Individuals with aspirin allergies
- People taking medications that interact poorly with aspirin
The Balance Between Benefits and Risks
Understanding the Bleeding Risk
Aspirin’s blood-thinning properties create a delicate balance. While this effect helps prevent dangerous blood clots, it simultaneously increases the risk of bleeding complications. For people without existing cardiovascular disease, the absolute risks of vascular events like heart attacks or strokes are lower, but the risks of bleeding remain comparable to those taking aspirin for secondary prevention.
This means that for primary prevention in generally healthy individuals, taking aspirin to reduce a relatively small cardiovascular risk comes with a substantial bleeding risk—a trade-off that doesn’t typically favor aspirin use.
Changing Risk Profiles in Modern Times
One reason for the shift away from routine aspirin use for primary prevention relates to improvements in modern cardiovascular health. Heart attack rates have declined significantly in contemporary society due to lower smoking rates, better treatment of blood pressure, and improved cholesterol management. This means that the baseline risk for initially healthy people experiencing a cardiovascular event is lower than it was during earlier eras when aspirin was more broadly recommended.
Global Aspirin Use Patterns
Despite the proven benefits of aspirin for secondary prevention, its use remains suboptimal worldwide. Among people with a history of cardiovascular disease, only about 40% reported taking aspirin to prevent another heart attack, stroke, or cardiovascular event. This proportion varies significantly by country and economic status:
- Low-income countries: 16.6% of eligible patients taking aspirin
- Lower-middle-income countries: 24.5%
- Upper-middle-income countries: 51.1%
- High-income countries: 65%
The World Health Organization has set a target for at least 50% of eligible people to receive drug therapy and counseling to prevent cardiovascular events, yet global uptake remains below this goal. This underutilization of an effective, inexpensive therapy represents a significant public health opportunity.
What to Do If You Have a Heart Attack
In the acute setting of a suspected heart attack, aspirin plays an important immediate role. If you believe you’re experiencing a heart attack and have not been instructed otherwise by your doctor, chewing an aspirin can help delay the formation of blood clots that could further block your arteries.
By chewing the aspirin rather than swallowing it whole, you release more of the medicine directly into your stomach, which hastens its ability to enter your bloodstream and work more quickly. However, this emergency use should only be pursued if you have not been told by your doctor to avoid aspirin and if you are not allergic to it.
The Importance of Personalized Medical Advice
One of the most critical messages from updated medical guidelines is that aspirin decisions must be individualized. There is sometimes significant misunderstanding among both patients and healthcare providers about who should take aspirin for prevention. What’s appropriate for one person may not be appropriate for another, depending on individual risk factors, medical history, bleeding risk, and other considerations.
Your healthcare provider can evaluate your specific situation by considering factors such as:
- Your age and sex
- Your personal cardiovascular history
- Your family history of heart disease and stroke
- Your blood pressure and cholesterol levels
- Your smoking status
- Your bleeding risk and history
- Other medications you take
- Results of cardiovascular screening tests if available
Frequently Asked Questions
Q: Can I start taking aspirin on my own to prevent a heart attack?
A: No. Aspirin should only be started on the recommendation of your healthcare provider. While it can be beneficial for certain people, it carries risks that may outweigh benefits for others, particularly healthy adults without prior cardiovascular events. Consult your doctor before beginning aspirin therapy.
Q: If I’ve had a heart attack, should I definitely take aspirin?
A: In most cases, yes. People who have survived a heart attack benefit significantly from aspirin for secondary prevention. Your doctor will likely recommend it unless you have specific contraindications such as aspirin allergies or bleeding disorders. This is one of the clearest indications for aspirin use.
Q: Is low-dose aspirin safer than regular-strength aspirin?
A: Low-dose aspirin (typically 75-100 mg daily) is generally used for cardiovascular prevention because it provides antiplatelet benefits with potentially lower bleeding risk compared to higher doses. Your healthcare provider will recommend the appropriate dose for your situation.
Q: What should I do if I experience side effects from aspirin?
A: Common side effects include stomach upset or heartburn. Report any concerning symptoms to your healthcare provider, especially signs of bleeding such as unusual bruising, blood in stool, or nosebleeds. Do not stop taking aspirin without medical guidance.
Q: Can aspirin replace other cardiovascular medications?
A: No. Aspirin is typically used in combination with other medications for cardiovascular disease management, not as a replacement. Medications for blood pressure control, cholesterol management, and other conditions may all play important roles in your cardiovascular health alongside aspirin if it’s appropriate for you.
Q: How long should I take aspirin if it’s recommended for me?
A: For secondary prevention after a heart attack or stroke, aspirin is typically recommended as a long-term therapy indefinitely, unless contraindicated. Your healthcare provider will determine the appropriate duration for your specific situation.
References
- Aspirin Can Help Reduce Risk of Second Heart Attack, But Study Finds Less Than Half of Eligible Adults Take It — CBS News / CNN. 2024. https://www.cbsnews.com/detroit/news/aspirin-can-help-reduce-risk-of-second-heart-attack-but-study-finds-less-than-half-of-eligible-adults-take-it/
- Avoid Daily Aspirin Unless Your Doctor Prescribes It, New Guidelines Advise — American Heart Association. 2019-03-18. https://www.heart.org/en/news/2019/03/18/avoid-daily-aspirin-unless-your-doctor-prescribes-it-new-guidelines-advise
- US Population Qualifying for Aspirin Use for Primary Prevention of Cardiovascular Disease — Johns Hopkins University Press. 2022. https://pure.johnshopkins.edu/en/publications/us-population-qualifying-for-aspirin-use-for-primary-prevention-o/
- Survive a Heart Attack When Alone — Johns Hopkins Aramco Healthcare. https://www.jhah.com/en/news-events/news-articles/survive-a-heart-attack-when-alone/
- The Role of Low-Dose Aspirin Along the Cardiovascular Risk Continuum — Johns Hopkins University Press. https://pure.johnshopkins.edu/en/publications/needs-based-considerations-for-the-role-of-low-dose-aspirin-along/
- Contextualizing National Policies Regulating Access to Low-Dose Aspirin — National Center for Biotechnology Information / PubMed. 2022. https://pubmed.ncbi.nlm.nih.gov/35411788/
Read full bio of Sneha Tete














